Open call for evidence: Regulation of AI in Healthcare (Deadline for responses is 11:59pm on 2 February 2026)

Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) is seeking evidence on the regulation of artificial intelligence (AI) in healthcare to inform the recommendations of the National Commission into the Regulation of AI in Healthcare.

This call for evidence closes at 11:59pm on 2 February 2026.

Content

Who can take part

This Call for Evidence invites contributions from people and organisations across the UK and internationally. The information gathered will help inform the Commission’s recommendations and help address key challenges in regulating AI in healthcare.

Other opportunities such as workshops are also planned to hear directly from patients and members of the public.

Anyone can take part, but they especially want to hear from:

• Patients, the public, and charities
• AI health tech companies and industry groups
• NHS and independent healthcare leaders and health and care professionals
• Healthcare provider organisations and professional bodies
• UK and international healthcare regulators

Topics considered in the Call for Evidence

The Call for Evidence invites evidence and views on:

• whether the UK’s framework for regulating AI in healthcare is sufficient
• how the UK’s regulatory framework may need to be improved to ensure fast access to safe and effective AI medical devices
• approaches to checking safety once AI medical devices are in use
• how responsibility and liability are managed between different parties involved in the deployment of AI medical devices.